Alaunos Therapeutics (TCRT) Institutional Ownership $2.15 +0.02 (+0.94%) (As of 11:35 AM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alaunos Therapeutics (NASDAQ:TCRT)CurrentInstitutional OwnershipPercentage27.72%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$532.85KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$90.66M Get TCRT Insider Trade Alerts Want to know when executives and insiders are buying or selling Alaunos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCRT Institutional Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Alaunos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 MSD Partners L.P.101,010$325K0.2%-90.0%6.313% 5/20/2024Virtu Financial LLC15,440$28K0.0%N/A0.096% 5/2/2024 Magnolia Capital Advisors LLC24,695$45K0.0%-93.8%0.154% 4/30/2024 Fortis Group Advisors LLC13,999$25K0.0%N/A0.087% 2/20/2024 MSD Partners L.P.15,151,516$1.07M0.1%-33.3%94.402% 2/9/2024 Commerce Bank437,000$31K0.0%-4.8%2.723% Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/2/2024 Magnolia Capital Advisors LLC401,507$28K0.0%-7.3%0.167% 11/4/2023 Magnolia Capital Advisors LLC432,969$56K0.1%N/A0.180% 7/20/2023 Allred Capital Management LLC253,000$129K0.1%+24.6%0.105% 5/12/2023 CIBC Private Wealth Group LLC50,400$32K0.0%+65.8%0.021% 4/21/2023 Chiron Capital Management LLC81,830$52K0.0%-22.7%0.034% 2/15/2023 Allred Capital Management LLC193,000$125K0.1%+22.2%0.089% 2/14/2023 Discovery Capital Management LLC CT16,185,998$10.51M1.5%+10.5%7.487% 2/13/2023 GSA Capital Partners LLP957,348$621K0.1%+57.4%0.443% 1/30/2023 Welch Group LLC43,000$28K0.0%-26.7%0.020% 1/9/2023Addison Capital Co15,870$2.32M1.5%N/A0.007% 11/15/2022 Laurion Capital Management LP4,220,500$7.26M0.0%-1.6%1.952% 11/15/2022 Magnolia Capital Advisors LLC418,569$720K0.6%+25.1%0.194% 11/15/2022 Boxer Capital LLC1,500,000$2.58M0.1%N/A0.694% 11/15/2022 Caxton Associates LP311,974$537K0.1%+209.8%0.144% 11/14/2022 Zacks Investment Management44,550$77K0.0%N/A0.021% 11/14/2022 Tudor Investment Corp Et Al39,374$68K0.0%-88.1%0.018% 11/14/2022 Cubist Systematic Strategies LLC349,867$602K0.0%+4,589.3%0.162% 11/14/2022Ergoteles LLC485,434$835K0.0%-48.2%0.225% 11/14/2022 E Fund Management Co. Ltd.15,167$26K0.0%N/A0.007% 11/7/2022Virtu Financial LLC74,592$128K0.0%N/A0.035% 11/3/2022 Mutual Advisors LLC22,095$38K0.0%-40.4%0.010% 11/3/2022 Barclays PLC136,136$234K0.0%N/A0.063% 10/31/2022 Concorde Asset Management LLC35,500$61K0.1%N/A0.016% 10/31/2022 Green Square Capital Advisors LLC1,080,000$1.86M0.3%N/A0.500% 10/26/2022 Belvedere Trading LLC66,493$78K0.0%N/A0.031% 10/24/2022 ACT Wealth Management LLC38,476$66K0.0%N/A0.018% 10/17/2022 SevenBridge Financial Group LLC20,000$34K0.0%N/A0.009% 10/14/2022 Private Advisor Group LLC119,374$206K0.0%N/A0.055% 10/13/2022 Chiron Capital Management LLC116,860$201K0.1%N/A0.054% 10/13/2022 Welch Group LLC58,700$101K0.0%N/A0.027% 10/11/2022 Sugarloaf Wealth Management LLC79,050$136K0.0%N/A0.037% 10/4/2022 AdvisorNet Financial Inc42,329$73K0.0%N/A0.020% 8/16/2022 Discovery Capital Management LLC CT14,125,079$17.52M2.3%N/A6.541% 8/15/2022 Laurion Capital Management LP4,289,193$5.32M0.1%N/A1.986% Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide8/15/2022 Kettle Hill Capital Management LLC344,400$427K0.1%N/A0.159% 8/12/2022 Commerce Bank459,000$569K0.0%N/A0.213% 8/10/2022 Synovus Financial Corp33,000$41K0.0%N/A0.015% 8/8/2022 Nicolet Advisory Services LLC21,500$30K0.0%N/A0.010% 8/8/2022 Oppenheimer & Co. Inc.45,500$56K0.0%N/A0.021% 8/8/2022 Y Intercept Hong Kong Ltd25,079$31K0.0%N/A0.012% 8/5/2022Gamble Jones Investment Counsel61,000$76K0.0%N/A0.028% 8/5/2022 Horizon Kinetics Asset Management LLC34,000$42K0.0%N/A0.016% 8/4/2022 Steward Partners Investment Advisory LLC36,106$45K0.0%N/A0.017% 8/3/2022 CIBC Private Wealth Group LLC41,490$51K0.0%N/A0.019% 8/3/2022 Stephens Inc. AR25,162$31K0.0%N/A0.012% 8/3/2022 Janney Montgomery Scott LLC82,412$101K0.0%N/A0.038% (Data available from 1/1/2016 forward) TCRT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCRT shares? During the previous two years, 12 institutional investors and hedge funds held shares of Alaunos Therapeutics. The most heavily invested institutionals were Discovery Capital Management LLC CT ($10.51M), Addison Capital Co ($2.32M), GSA Capital Partners LLP ($621K), MSD Partners L.P. ($325K), Allred Capital Management LLC ($129K), Chiron Capital Management LLC ($52K), and Magnolia Capital Advisors LLC ($45K).Learn more on TCRT's institutional investors. What percentage of Alaunos Therapeutics stock is owned by institutional investors? 27.72% of Alaunos Therapeutics stock is owned by institutional investors. Learn more on TCRT's institutional investor holdings. Which institutional investors have been buying Alaunos Therapeutics stock? The following institutional investors have purchased Alaunos Therapeutics stock in the last 24 months: Discovery Capital Management LLC CT ($1.54M), Magnolia Capital Advisors LLC ($432.97K), GSA Capital Partners LLP ($349.31K), Allred Capital Management LLC ($85K), CIBC Private Wealth Group LLC ($20K), Addison Capital Co ($15.87K), and Virtu Financial LLC ($15.44K). How much institutional buying is happening at Alaunos Therapeutics? Institutional investors have bought a total of 2,475,628 shares in the last 24 months. This purchase volume represents approximately $204.01M in transactions. Which Alaunos Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Alaunos Therapeutics stock in the last 24 months: MSD Partners L.P. ($8.48M), Magnolia Capital Advisors LLC ($408.27K), Chiron Capital Management LLC ($24.06K), Commerce Bank ($22K), and Welch Group LLC ($15.70K). How much institutional selling is happening at Alaunos Therapeutics? Institutional investors have sold a total of 8,954,883 shares in the last 24 months. This volume of shares sold represents approximately $94.46M in transactions. Related Companies Akari Therapeutics Major Shareholders Sol-Gel Technologies Major Shareholders PharmaCyte Biotech Major Shareholders NLS Pharmaceutics Major Shareholders AIM ImmunoTech Major Shareholders Talphera Major Shareholders Sensei Biotherapeutics Major Shareholders Aspira Women's Health Major Shareholders NKGen Biotech Major Shareholders ImmunoPrecise Antibodies Major Shareholders This page (NASDAQ:TCRT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
